Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.

Geller S, Busam K, Hamlin PA, Moskowitz AJ, Horwitz SM, Myskowski PL.

J Dermatolog Treat. 2018 Nov 19:1-3. doi: 10.1080/09546634.2018.1528001. [Epub ahead of print]

PMID:
30244619
2.

Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.

Lebowitz E, Geller S, Flores E, Pulitzer M, Horwitz S, Moskowitz A, Kheterpal M, Myskowski PL.

J Eur Acad Dermatol Venereol. 2018 Sep 3. doi: 10.1111/jdv.15236. [Epub ahead of print]

PMID:
30176169
3.

Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.

Geller S, Dickson MA, Busam KJ, Myskowski PL.

J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25. No abstract available.

PMID:
30044684
4.

Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW.

Cancer Immunol Res. 2018 Aug;6(8):900-909. doi: 10.1158/2326-6066.CIR-17-0270. Epub 2018 Jun 12.

PMID:
29895574
5.

Acneiform follicular mucinosis: an indolent follicular mucinosis variant unrelated to mycosis fungoides?

Geller S, Pulitzer M, Myskowski PL.

Clin Exp Dermatol. 2018 Dec;43(8):921-924. doi: 10.1111/ced.13671. Epub 2018 May 30.

PMID:
29851124
6.

Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy.

Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e279-e281. doi: 10.1016/j.clml.2018.04.010. Epub 2018 May 4. No abstract available.

PMID:
29752211
7.
8.

Diffuse eruptive ulcerated plaques.

Geller S, Pulitzer M, Myskowski PL.

Int J Dermatol. 2018 Sep;57(9):1055-1057. doi: 10.1111/ijd.14017. Epub 2018 Apr 24. No abstract available.

PMID:
29693247
9.

Solitary orange papule on the back of a middle-aged man.

Geller S, Pulitzer M, Myskowski PL.

Dermatol Pract Concept. 2018 Jan 31;8(1):51-53. doi: 10.5826/dpc.0801a11. eCollection 2018 Jan. No abstract available.

10.

Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.

Phillips GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, Barrios DM, Ciccolini K, Marchetti MA, Deng L, Myskowski PL, Lee EH, Markova A, Lacouture ME.

J Am Acad Dermatol. 2018 Jun;78(6):1102-1109. doi: 10.1016/j.jaad.2017.12.031. Epub 2017 Dec 19.

PMID:
29273489
11.

Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.

Warren S, Kheterpal M, Myskowski PL, Moskowitz A, Horwitz SM, Pulitzer MP.

J Am Acad Dermatol. 2018 Mar;78(3):530-539. doi: 10.1016/j.jaad.2017.09.015. Epub 2017 Nov 10.

PMID:
29132694
12.

Dermoscopic assessment of vascular structures in solitary small pink lesions-differentiating between good and evil.

Geller S, Pulitzer M, Brady MS, Myskowski PL.

Dermatol Pract Concept. 2017 Jul 31;7(3):47-50. doi: 10.5826/dpc.0703a10. eCollection 2017 Jul.

13.

ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.

Geller S, Canavan TN, Pulitzer M, Moskowitz AJ, Myskowski PL.

Int J Dermatol. 2018 May;57(5):515-520. doi: 10.1111/ijd.13804. Epub 2017 Oct 23. Review.

PMID:
29057463
14.

The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?

Geller S, Myskowski PL, Kim YH, Moskowitz A, Horwitz S.

Br J Dermatol. 2018 Feb;178(2):571. doi: 10.1111/bjd.16052. Epub 2017 Dec 18. No abstract available.

PMID:
29023638
15.

Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma.

Geller S, Marghoob AA, Scope A, Braun RP, Myskowski PL.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):53-56. doi: 10.1111/jdv.14549. Epub 2017 Sep 12.

PMID:
28846171
16.

Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.

Virmani P, Levin L, Myskowski PL, Flores E, Marchetti MA, Lucas AS, Pulitzer M, Horwitz S, Trippett T, Moskowitz A, Querfeld C.

Pediatr Dermatol. 2017 Sep;34(5):547-553. doi: 10.1111/pde.13226. Epub 2017 Aug 14.

17.

Acral angiokeratoma-like pseudolymphoma in a middle-aged woman.

Geller S, Markova A, Pulitzer M, Myskowski PL.

J Cutan Pathol. 2017 Oct;44(10):878-881. doi: 10.1111/cup.12999. Epub 2017 Jul 24.

18.

Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab.

Virmani P, Busam K, Myskowski PL, Yang A, Magro C, Horwitz S.

JAAD Case Rep. 2017 Jun 14;3(4):269-272. doi: 10.1016/j.jdcr.2017.02.024. eCollection 2017 Jul. No abstract available.

19.

Post-reconstruction dermatitis of the breast.

Rosen AC, Goh C, Lacouture ME, Mehrara BJ, Cordeiro PG, Myskowski PL.

J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1369-1376. doi: 10.1016/j.bjps.2017.05.012. Epub 2017 May 20.

20.

Handheld Reflectance Confocal Microscopy for the Detection of Recurrent Extramammary Paget Disease.

Yélamos O, Hibler BP, Cordova M, Hollmann TJ, Kose K, Marchetti MA, Myskowski PL, Pulitzer MP, Rajadhyaksha M, Rossi AM, Jain M.

JAMA Dermatol. 2017 Jul 1;153(7):689-693. doi: 10.1001/jamadermatol.2017.0619.

21.

Inflamed Actinic Keratoses After Pemetrexed.

Cameron MC, Suárez AL, Kris MG, Myskowski PL.

Skinmed. 2016 Dec 1;14(6):473-474. eCollection 2016.

PMID:
28031141
22.

Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience.

Virmani P, Jawed S, Myskowski PL, Horwitz S, Skripnik Lucas A, Moskowitz A, Pulitzer M, Zain J, Rosen ST, Querfeld C.

Int J Dermatol. 2016 Nov;55(11):1248-1254. doi: 10.1111/ijd.13340.

23.

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Kheterpal M, Mehta-Shah N, Virmani P, Myskowski PL, Moskowitz A, Horwitz SM.

Curr Hematol Malig Rep. 2016 Jun;11(3):224-33. doi: 10.1007/s11899-016-0322-5. Review.

24.

Unusual variants of mycosis fungoides.

Virmani P, Myskowski PL, Pulitzer M.

Diagn Histopathol (Oxf). 2016 Apr;22(4):142-151. doi: 10.1016/j.mpdhp.2016.04.004. Epub 2016 May 21.

25.

Reflectance confocal microscopy features of mycosis fungoides and Sézary syndrome: correlation with histopathologic and T-cell receptor rearrangement studies.

Mancebo SE, Cordova M, Myskowski PL, Flores ES, Busam K, Jawed SI, Skripnik A, Rajadhyaksha M, Querfeld C.

J Cutan Pathol. 2016 Jun;43(6):505-15. doi: 10.1111/cup.12708. Epub 2016 Apr 8.

26.

Jejunal adenocarcinoma with cutaneous metastasis.

Chung E, Syklawer E, Pulitzer MP, Marchetti MA, Querfeld C, Myskowski PL.

Dermatol Online J. 2015 Jul 15;21(7). pii: 13030/qt2fh785fw.

PMID:
26436979
27.

Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.

Virmani P, Zain J, Rosen ST, Myskowski PL, Querfeld C.

Dermatol Clin. 2015 Oct;33(4):807-18. doi: 10.1016/j.det.2015.05.014. Epub 2015 Jul 29. Review.

28.

Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).

Suárez AL, Louis P, Kitts J, Busam K, Myskowski PL, Wong RJ, Chen CS, Spencer P, Lacouture M, Pulitzer MP.

J Am Acad Dermatol. 2015 Dec;73(6):968-75. doi: 10.1016/j.jaad.2015.08.041. Epub 2015 Oct 2.

29.

Review of drug-related causes of oculocutaneous disease.

Cameron MC, Suárez AL, Myskowski PL.

J Am Acad Dermatol. 2015 Feb;72(2):361-2. doi: 10.1016/j.jaad.2014.08.054. No abstract available.

PMID:
25592348
30.

Treatment response of cutaneous mantle cell lymphoma to ibrutinib and radiotherapy.

Mancebo SE, Smith JR, Intlekofer AM, Zelenetz AD, Myskowski PL.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e113-5. doi: 10.1016/j.clml.2014.11.003. Epub 2014 Nov 18. No abstract available.

PMID:
25499623
31.

Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.

Marchetti MA, Pulitzer MP, Myskowski PL, Dusza SW, Lunning MA, Horwitz SM, Moskowitz AJ, Querfeld C.

J Am Acad Dermatol. 2015 Feb;72(2):293-301. doi: 10.1016/j.jaad.2014.10.006. Epub 2014 Nov 8.

PMID:
25455841
32.

Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.

Pulitzer M, Myskowski PL, Horwitz SM, Querfeld C, Connolly B, Li J, Murali R.

Pathology. 2014 Dec;46(7):610-6. doi: 10.1097/PAT.0000000000000166.

33.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. Review.

PMID:
24438970
34.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. Review.

PMID:
24438969
35.

Generational gap regarding patients' driving habits.

Garden BC, Myskowski PL.

J Am Acad Dermatol. 2014 Feb;70(2):387. doi: 10.1016/j.jaad.2013.09.059. No abstract available.

PMID:
24438962
36.

Dermoscopic findings in cutaneous metastases.

Chernoff KA, Marghoob AA, Lacouture ME, Deng L, Busam KJ, Myskowski PL.

JAMA Dermatol. 2014 Apr;150(4):429-33. doi: 10.1001/jamadermatol.2013.8502.

PMID:
24430974
37.

Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face.

Li JY, Guitart J, Pulitzer MP, Subtil A, Sundram U, Kim Y, Deonizio J, Myskowski PL, Moskowitz A, Horwitz S, Querfeld C.

Am J Dermatopathol. 2014 May;36(5):402-8. doi: 10.1097/DAD.0b013e3182a74c7a.

PMID:
24394306
38.

Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.

Straus DJ, Duvic M, Horwitz SM, Hymes K, Goy A, Hernandez-Ilizaliturri FJ, Feldman T, Wegner B, Myskowski PL.

Ann Oncol. 2014 Jan;25(1):206-10. doi: 10.1093/annonc/mdt480. Epub 2013 Nov 26.

PMID:
24285015
39.

Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.

Suárez AL, Querfeld C, Horwitz S, Pulitzer M, Moskowitz A, Myskowski PL.

J Am Acad Dermatol. 2013 Sep;69(3):343.e1-11; quiz 355-6. doi: 10.1016/j.jaad.2013.06.011. Review.

PMID:
23957985
40.

Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.

Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL.

J Am Acad Dermatol. 2013 Sep;69(3):329.e1-13; quiz 341-2. doi: 10.1016/j.jaad.2013.06.012. Review.

PMID:
23957984
41.

Nonimmediate hypersensitivity reaction after trastuzumab infusion: a suspected drug-virus interaction.

Ferastraoaru DE, Dickler MN, Patel S, Fischer EA, Pulitzer MP, Myskowski PL, Jerschow E.

J Clin Oncol. 2013 Aug 20;31(24):e407-9. doi: 10.1200/JCO.2012.45.9958. Epub 2013 Jun 10. No abstract available.

PMID:
23752107
42.

A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.

Li JY, Pulitzer MP, Myskowski PL, Dusza SW, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2013 Sep;69(3):366-74. doi: 10.1016/j.jaad.2013.03.036. Epub 2013 May 16.

PMID:
23685027
43.

Analysis of dermatologic events in vemurafenib-treated patients with melanoma.

Lacouture ME, Duvic M, Hauschild A, Prieto VG, Robert C, Schadendorf D, Kim CC, McCormack CJ, Myskowski PL, Spleiss O, Trunzer K, Su F, Nelson B, Nolop KB, Grippo JF, Lee RJ, Klimek MJ, Troy JL, Joe AK.

Oncologist. 2013;18(3):314-22. doi: 10.1634/theoncologist.2012-0333. Epub 2013 Mar 1.

44.

Cryotherapy for primary cutaneous B-cell lymphoma.

Kennedy-Crispin M, Myskowski PL.

J Am Acad Dermatol. 2012 Dec;67(6):e292-4. doi: 10.1016/j.jaad.2012.07.010. No abstract available.

PMID:
23158647
45.

Dermoscopy: an aid to the detection of amelanotic cutaneous melanoma metastases.

Jaimes N, Halpern JA, Puig S, Malvehy J, Myskowski PL, Braun RP, Marghoob AA.

Dermatol Surg. 2012 Sep;38(9):1437-44. doi: 10.1111/j.1524-4725.2012.02438.x. Epub 2012 May 15.

PMID:
22587541
46.

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C.

Cancer Manag Res. 2012;4:75-89. doi: 10.2147/CMAR.S9660. Epub 2012 Mar 12.

47.

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

Balagula Y, Rosen A, Tan BH, Busam KJ, Pulitzer MP, Motzer RJ, Feldman DR, Konner JA, Reidy-Lagunes D, Myskowski PL, Lacouture ME.

Cancer. 2012 Oct 15;118(20):5078-83. doi: 10.1002/cncr.27505. Epub 2012 Mar 21.

48.

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.

Horwitz SM, Kim YH, Foss F, Zain JM, Myskowski PL, Lechowicz MJ, Fisher DC, Shustov AR, Bartlett NL, Delioukina ML, Koutsoukos T, Saunders ME, O'Connor OA, Duvic M.

Blood. 2012 May 3;119(18):4115-22. doi: 10.1182/blood-2011-11-390211. Epub 2012 Mar 6.

49.

Chronic cutaneous graft-versus-host disease simulating hypertrophic lupus erythematosus--a case report of a new morphologic variant of graft-versus-host disease.

Hu SW, Myskowski PL, Papadopoulos EB, Busam KJ.

Am J Dermatopathol. 2012 Aug;34(6):e81-3. doi: 10.1097/DAD.0b013e31823395f0.

PMID:
22307231
50.

Pigmentary changes in a patient treated with imatinib.

Balagula Y, Pulitzer MP, Maki RG, Myskowski PL.

J Drugs Dermatol. 2011 Sep;10(9):1062-6.

PMID:
22052279

Supplemental Content

Loading ...
Support Center